Abstract-Hypertension is a risk factor for cerebrovascular diseases, including stroke and dementia. During hypertension, arteries become constricted and are less responsive to vasodilators, including nitric oxide (NO). The regulation of arterial contractility by smooth muscle cell (myocyte) large-conductance calcium (Ca 2+ )-activated potassium (BK) channels is altered during hypertension, although mechanisms involved are unclear. We tested the hypothesis that dysfunctional trafficking of pore-forming BK channel (BKα) and auxiliary β1 subunits contributes to changes in cerebral artery contractility of stroke-prone spontaneously hypertensive rats (SP-SHRs). Our data indicate that the amounts of total and surface BKα and β1 proteins are similar in unstimulated arteries of age-matched SP-SHRs and normotensive Wistar-Kyoto rats. In contrast, stimulated surface-trafficking of β1 subunits by NO or membrane depolarization is inhibited in SP-SHR myocytes. PKCα (protein kinase C α) and PKCβII total protein and activity were both higher in SP-SHR than in Wistar-Kyoto rat arteries. NO or depolarization robustly activated Rab11, a small trafficking GTPase, in Wistar-Kyoto rat arteries but weakly activated Rab11 in SP-SHRs. Bisindolylmaleimide, a PKC inhibitor, and overexpression of a PKC phosphorylation-deficient Rab11A mutant (Rab11A S177A) restored stimulated β1 subunit surface-trafficking in SP-SHR myocytes. BK channel activation by NO was inhibited in SP-SHR myocytes and restored by Rab11A S177A expression. Vasodilation to NO and lithocholate, a BKα/β1 channel activator, was inhibited in pressurized SP-SHR arteries and reestablished by bisindolylmaleimide. In summary, data indicate that spontaneously active PKC inhibits Rab11A-mediated β1 subunit trafficking in arterial myocytes of SP-SHRs, leading to dysfunctional NO-induced BK channel activation and vasodilation. (Hypertension. 2018;72:765-775.
H ypertension is a risk factor for several cerebrovascular diseases, including stroke and dementia. During hypertension, cerebral arteries become constricted. [1] [2] [3] Cerebral arteries of hypertensive subjects are also less responsive to vasodilators, including nitric oxide (NO). 4 These pathological alterations can restrict regional brain blood flow, leading to insufficient perfusion to neurons, and other brain cell types. Mechanisms that lead to these pathological changes in arterial contractility during hypertension are incompletely understood.
Membrane potential is a principal regulator of arterial contractility. 5 Depolarization triggers the opening of voltagedependent L-type calcium (Ca 2+ ; Ca V 1.2) channels in arterial smooth muscle cells, leading to Ca 2+ influx and vasoconstriction. 6 In contrast, the opening of potassium channels, such as large conductance Ca 2+ -activated potassium (BK) channels, leads to membrane hyperpolarization and vasodilation. 6, 7 Discrepancy exists in literature studying pathological changes in cerebral artery myocyte BK channels in hypertensive subjects. Studies have proposed that BK channels upregulate in arterial myocytes during hypertension, eliciting compensatory vasodilation. 1 In contrast, a reduction BK channel activity is described to contribute to vasoconstriction in hypertension. [8] [9] [10] This inconsistency in findings highlights a necessity for additional studies.
Arterial smooth muscle cell BK channels are composed of a pore-forming α subunit (BKα) and auxiliary β1 and γ subunits. [11] [12] [13] The regulated trafficking of BK channel subunits is a functional mechanism to control arterial contractility. 12, 14 In resting arterial myocytes, virtually all BKα protein is located in the plasma membrane, whereas a large proportion of β1 is intracellular and contained within Rab11A-positive recycling endosomes. 12 NO, a vasodilator, activates Rab11A, which stimulates rapid anterograde β1 subunit trafficking. 12 Membrane depolarization also stimulates rapid β1 subunit surface trafficking through Ca 2+ dependent activation of ROCK (Rho-associated protein kinase) 1 and 2. 15 These surface-trafficked β1 subunits then associate with plasma-membrane-localized BKα subunits, September 2018 increasing their apparent Ca 2+ sensitivity and activity. 12, 14 ET-1 (endothelin-1), a vasoconstrictor, activated PKC (protein kinase C), which phosphorylated Rab11A at serine 177. 16 This mechanism reduced surface β1 trafficking, leading to BK channel inhibition in arterial myocytes and vasoconstriction. 16 In contrast to the regulated trafficking of β1 protein by Rab11A, BKα subunit anterograde trafficking is controlled by Rab4A-positive early endosomes in arterial myocytes. 17 Ang II (angiotensin II), a vasoconstrictor, stimulated PKC-dependent internalization and degradation of BKα subunits, which reduced transient BK currents and stimulated vasoconstriction. 17 These studies demonstrated that plasma membrane BK channel subunit composition is subject to modulation by physiological stimuli to control arterial contractility. Whether the trafficking of BK channel subunits is altered during cardiovascular diseases, leading to changes in BK channel functionality is unclear.
Here, we examined BK channel subunit trafficking in cerebral artery myocytes of stroke-prone spontaneously hypertensive rats (SP-SHRs), using age-matched WistarKyoto (WKY) rat arteries as controls. Our data indicate that spontaneously active PKC blocks the stimulated surface trafficking of β1 subunits. This inhibitory mechanism prevents BK channel activation by NO in arterial myocytes of SP-SHRs. A PKC inhibitor and overexpression of a mutant Rab11A that cannot be phosphorylated by PKC at serine 177 (Rab11A S177A) restored the stimulated surface trafficking of β1 subunits, BK channel activation, and vasodilation mediated by NO in SP-SHR arteries. These data indicate that activated PKC blocks β1 subunit surface trafficking, which inhibits BK channels and prevents vasodilation in cerebral arteries of SP-SHR.
Methods
The techniques and data that support the results of this study are available from the corresponding author on reasonable request.
Tissue Preparation
Animal protocols were reviewed and approved by the Animal Care and Use Committee at the University of Tennessee Health Science Center. Male WKY rats and SP-SHRs (12 weeks) were euthanized with sodium pentobarbital (150 mg/kg, IP). The brain was removed and placed in a HEPES-buffered physiological saline solution (PSS) containing the following (in mmol/L): 134 NaCl, 6 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 HEPES, and 10 glucose (pH=7.4). Cerebral arteries were dissected from the brain. Smooth muscle cells were isolated using papain and collagenase, as previously described.
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Arterial Surface Biotinylation
Intact arteries were biotinylated as previously described. 12, 19 Briefly, cerebral arteries were placed in 1 mg/mL EZ-Link Sulfo-NHS-LC-LC-Biotin and 1 mg/mL EZ-Link Maleimide-PEG 2 -Biotin (Pierce) in HEPES-buffered PSS for 1 hour. PBS with 100 mmol/L glycine was added to quench free biotin at the end of the incubation. Biotinylated arteries were homogenized in 1% Triton X-100 lysis buffer. The lysate was incubated with avidin beads (Thermo Fisher Scientific), then centrifuged at 13 000g. The beads were washed with PBS, and protein samples were eluted with Laemmli buffer (Bio-Rad) and boiled. Protein samples were analyzed using Western blotting.
Western Blotting
Protein samples were run on SDS-polyacrylamide gels and transferred onto nitrocellulose membranes. Blots were blocked with 5% nonfat dry milk and then probed with either rabbit polyclonal anti-BKβ1 (1:500, Abcam), mouse monoclonal anti-BKα (1:500, Neuromab, UC Davis), mouse monoclonal anti-actin (1:10 000, Millipore), rabbit polyclonal anti-PKCα (1:500, Cell Signaling), rabbit polyclonal anti-PKCβ (1:500, Santa Cruz), rabbit polyclonal anti-phospho PKCα/βII (Thr638/641, 1:500, Cell Signaling), rabbit monoclonal anti-rab11A (1:500, Cell Signaling), mouse monoclonal anti-active Rab11 (1:500, NewEast Biosciences), or mouse monoclonal anti-cytochrome C (1:500, Santa Cruz) antibodies overnight at 4°C. The blots were washed before incubating with horseradish peroxidase-conjugated secondary antibodies. After incubating with a chemiluminescent detection kit, blots were imaged using a Bio-Rad ChemiDoc Touch imaging system. Band intensity was quantified using Quantity One software (Bio-Rad). Blots were often washed using stripping buffer (Thermo Scientific) and reprobed with other antibodies. Total proteins were calculated by summation of surface and intracellular proteins, as done previously.
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Transfection of Intact Cerebral Arteries
A serine 177-to-alanine mutated Rab11A sequence (Rab11A S177A) was generated and subcloned into pcDNA3.1(+) (GenScript USA Inc, Piscataway, NJ). Cerebral arteries were transfected with empty pcDNA3.1 vectors, pcDNA3.1 encoding Rab11A, or pcDNA3.1 encoding Rab11A S177A using tandem-pulse electroporation (CUY21Vivo-SQ electroporator; Bex), as previously described. 21 Arteries were then cultured in serum-free Dulbecco modified Eagle's media supplemented with 1% penicillin-streptomycin under standard culture conditions for 2 days.
Patch Clamp Electrophysiology
BK channels were recorded using the inside-out patch clamp configuration. The bath and pipette solution both contained the following (in mmol/L): 130 KCl, 10 HEPES, 5 EGTA, 1.6 HEDTA, 1 MgCl 2 , and 10 μmol/L free Ca 2+ (pH=7.2). Currents were recorded using an Axopatch 200B amplifier and Clampex 10.3 at a holding potential of −40 or +80 mV. To study the effects on NO-mediated trafficking on BK channel properties, myocytes were first exposed to sodium nitroprusside (SNP), after which inside-out patches were pulled. SNP was then washed out before recording BK channels. Lithocholate was added directly to inside-out patches. Currents were filtered at 1 kHz, digitized at 5 kHz, and analyzed using Clampfit 10.3 (MDS Analytic Technologies).
Pressurized Artery Myography
Artery segments (1-2 mm length) were cannulated at each end in a perfusion chamber (Living Systems Instrumentation, St Albans, VT). Experiments were performed using a PSS, which contained (in mmol/L) 112 NaCl, 4.8 KCl, 24 NaHCO 3 , 1.8 CaCl 2 , 1.2 MgSO 4 , 1.2 KH 2 PQ 4 , and 10 glucose that was gassed with 21% O 2 , 5% CO 2 , and 74% N 2 . The endothelium was denuded by introducing air bubbles into the vessel lumen for ≈1 minute followed by wash with PSS. The chamber was continuously perfused with PSS and maintained at 37°C. Intravascular pressure was measured using a transducer. Arterial diameter was measured using a charge-coupled device camera attached to a Nikon TS100-F microscope and the edge-detection function of IonWizard (Ionoptix, Milton, MA). Myogenic tone (%) was calculated as follows: 100×(1-D active /D passive ), where D active is active arterial diameter and D passive is the diameter determined in Ca 2+ -free PSS supplemented with 5 mmol/L EGTA.
Statistical Analysis
Statistical analyses were performed using Origin v6.0 and GraphPad Prism v4.0. Values are indicated as mean±SEM. Student t test was used to compare paired and unpaired data from 2 populations. ANOVA with Newman-Keuls post hoc test was used for multiple group comparisons. P<0.05 was considered as significant. Power analysis was performed to verify that the sample size gave a value of >0.8 if P was >0.05.
Results
β1 Subunit Surface Trafficking Is Impaired in Cerebral Arteries of SP-SHRs
MAPs were 123±3 and 190±4 mm Hg in male WKY rats and SP-SHRs, respectively (n=6; P<0.05). Arterial biotinylation followed by Western blotting was performed to measure both the surface to intracellular distribution and total protein of BKα and β1 in cerebral arteries of WKYs and SP-SHRs. BKα and β1 subunit total (surface+intracellular) proteins were similar in cerebral arteries of WKYs and SP-SHRs ( Figure 1A and 1C). BKα and β1 proteins were also similarly distributed in cerebral arteries of WKYs and SP-SHR with >85% of BKα present in the plasma membrane and >90% of β1 located intracellularly ( Figure 1A and 1C) . Cytochrome C, a mitochondrial protein, was detected only in the intracellular fraction of WKY and SP-SHR arteries, indicating that biotin did not label intracellular proteins, as shown previously ( Figure 1D ). 16 These data indicate that BKα and β1 subunit total protein and cellular distribution are similar in unstimulated cerebral arteries of WKYs and SP-SHR.
We tested the hypothesis that trafficking of BK channel subunits induced by vasoactive stimuli is altered in cerebral arteries of SP-SHR during hypertension. Responses were measured to SNP, an NO donor, or membrane depolarization, which was induced by increasing extracellular K + to either 30 or 60 mmol/L (10 minutes each). SNP, 30 and 60 mmol/L K + increased surface β1 protein ≈2.2-, 2.3-, and 2.5-fold, respectively, in WKY arteries ( Figure 1A and 1C). In contrast, SNP SNP, 30 and 60 mmol/L K + did not alter surface β1 protein levels in SP-SHR arteries ( Figure 1A and 1C) . SNP, 30 and 60 mmol/L K + (10 minutes) did not alter surface levels of BKα in both WKY and SP-SHR arteries ( Figure 1A and 1C). These data indicate that SNP-and depolarization-induced β1 subunit surface trafficking is functional in myocytes of WKY rat arteries but is absent in myocytes of SP-SHR arteries.
BK Channel Activity Is Reduced Because of Impaired β1 Subunit Trafficking in Myocytes of SP-SHRs
To investigate the functional consequences of inhibited β1 subunit trafficking, BK channel open probability (P O ) was measured in inside-out patches pulled from cerebral artery myocytes. P O was measured at −40 mV, a physiological membrane potential, or at +80 mV to stimulate maximal channel activity, using a free intracellular Ca 2+ concentration of 10 µmol/L. At −40 mV, the mean P O of BK channels was similar in patches from control WKY and SP-SHR myocytes (Figure 2A and 2B). Lithocholate, an activator of β1 subunit-containing BK channels, was applied directly to inside-out patches. Lithocholate increased BK channel P O ≈2.4-fold in patches pulled from WKY rat myocytes but did not alter P O in patches from SP-SHR myocytes (Figure 2A and 2B ). Myocytes were exposed to SNP (10 minutes), after which patches were pulled and the P O of BK channels measured in inside-out patches in the absence of SNP. Myocyte SNP treatment increased the P O of BK channels ≈2.5-fold in patches from WKYs but did not alter the P O in patches from SP-SHRs (Figure 2A and 2B) . Lithocholate increased BK channel P O in patches from SNPtreated WKY rat myocytes such that it was ≈4.1-fold higher than in the control condition (Figure 2A and 2B) . In contrast, lithocholate did not activate BK channels in patches from SNP-treated SP-SHR myocytes (Figure 2A and 2B). These data suggest that in WKY rat myocytes, some β1 subunits are associated with surface BK channels and that NO stimulates an increase in the amount of surface β1 subunits associated with BKα, which increases P O and activation by a β1 ligand. In contrast, in SP-SHR myocytes, surface β1 subunits do not seem to be associated with BKα and NO does not stimulate β1 subunit surface trafficking to activate BK channels.
Activated PKC Inhibits β1 Subunit Surface Trafficking in SP-SHR Arteries
To evaluate the mechanism underlying inhibited β1 subunit trafficking, WKY and SP-SHR arteries were exposed to SNP in the presence or absence of bisindolylmaleimide (BIM), a PKC inhibitor. SNP alone increased surface β1 protein in WKY arteries but did not alter surface β1 in SP-SHR arteries ( Figure 3A and 3B) . BIM alone did not alter surface β1 protein in both WKY and SP-SHR arteries ( Figure 3A and 3B) . In WKY rat arteries, SNP similarly increased surface β1 when applied in the absence or presence of BIM ( Figure 3A and 3B) . BIM-enabled SNP to increase surface β1 subunits ≈2.7-fold in SP-SHR arteries ( Figure 3A and 3B) . Indeed, in the presence of BIM, the SNP-induced increase in surface β1 subunits was the same as in WKY arteries ( Figure 3A and 3B) . BKα distribution was not altered by SNP or BIM applied either alone or in combination in WKY or SP-SHR arteries ( Figure 3A and 3B). These data indicate that a PKC inhibitor enables NO-induced β1 subunit surface trafficking in SP-SHR arteries.
Western blotting was performed to measure PKC protein and activity in WKY and SP-SHR arteries. PKCα and βII proteins were ≈2.02-and 1.67-fold higher, respectively, in SP-SHR than WKY rat arteries ( Figure 3C and 3D ). An antibody that recognizes activated PKCα and βII indicated that the combined activity of these kinases was ≈1.89-fold higher in SP-SHR than WKY rat arteries ( Figure 3C and 3D ). These data indicate that both the total amounts of PKCα and βII and their combined activity are higher in SP-SHR than WKY rat arteries.
Rab11A S177A Restores β1 Subunit Surface Trafficking in SP-SHR Arteries
Rab11A-positive recycling endosomes traffic β1 subunits to the plasma membrane in arterial smooth muscle cells. 12, 16 To determine whether attenuated β1 subunit trafficking is related to a reduced function of Rab11A, both total Rab11A and active Rab11 were measured in WKY rat and SP-SHR arteries. Western blotting demonstrated that total Rab11A in unstimulated SP-SHR arteries was ≈48% of that in WKY rat arteries ( Figure 4A and 4B). SNP and 30 mmol/L K + increased active Rab11 ≈1.96-and 2.14-fold, respectively, in WKY rat arteries ( Figure 4A and 4B) . In contrast, SNP and 30 mmol/L K + increased active Rab11 only ≈1.19-and 1.29-fold, respectively, in SP-SHR rat arteries ( Figure 4A and 4B) . These data indicate that Rab11A total protein is lower and Rab11 activation by SNP and membrane depolarization are both inhibited in SP-SHR arteries.
ET-1 activates PKC, which phosphorylates Rab11A at S177, leading to inhibition of β1 subunit surface trafficking in arterial myocytes. 16 Given that BIM restored β1 subunit trafficking in SP-SHR arteries, we evaluated the function of Rab11A S177A. Arteries were transfected with an empty vector (mock), or vectors that express either Rab11A (Rab11A) or Rab11A S177A, a phosphorylation-deficient Rab11A mutant. Vectors encoding Rab11A or Rab11A S177A similarly increased Rab11A total protein to ≈163% or 160% of the mock group ( Figure 4A and 4B). SNP similarly stimulated a ≈3-fold increase in surface β1 subunits in WKY arteries overexpressing either Rab11A or Rab11A S177A ( Figure 4C and 4D) . SNP-induced surface trafficking of β1 subunits was impaired in SP-SHR cerebral arteries expressing Rab11A ( Figure 4E and 4F) . In contrast, Rab11A S177A expression enabled SNP-induced surface trafficking of β1 in SP-SHR arteries ( Figure 4E and 4F) . These data suggest that PKC-mediated phosphorylation of Rab11A S177 inhibits β1 surface trafficking in SP-SHR arteries.
Rab11A S177A Restores BK Channel Activation in SP-SHR Arterial Myocytes
To examine the modulation of BK channel P O by Rab11A S177, myocytes were isolated from WKY or SP-SHR arteries overexpressing Rab11A or Rab11A S177A. Myocytes were exposed to SNP (10 minutes), after which inside-out patches were pulled and BK channels recorded at −40 or +80 mV in the absence of SNP. BK channel P O was similar in WKY rat myocytes overexpressing either Rab11A or Rab11A S177A ( Figure 5A and 5B). In patches from SP-SHR myocytes expressing Rab11A, mean BK channel P O was ≈60% of that in WKY myocytes expressing the same construct ( Figure 5A and 5B). The expression of Rab11A S177A increased BK channel P O in SP-SHR myocytes, such that it was the same as in WKY myocytes under the same condition ( Figure 5A and 5B). The application of lithocholate to inside-out patches similarly increased BK channel P O ≈1.8-fold in WKY rat myocytes overexpressing either Rab11A or Rab11A S177A ( Figure 5A and 5B). Lithocholate did not increase BK channel P O in SP-SHR myocytes overexpressing Rab11A ( Figure 5A and 5B). In contrast, Rab11A S177A expression enabled lithocholate-induced activation of BK channels in SNP-treated SP-SHR myocytes, such that P O was the same as in WKY rat myocytes under the same condition ( Figure 5A and 5B). These data indicate that Rab11A S177A expression restores SNP-induced BK channel activation in SP-SHR myocytes. These results support other evidence presented here that PKC-mediated phosphorylation of Rab11A S177 blocks BK channels in SP-SHR myocytes.
Impaired β1 Subunit Trafficking Attenuates BK Channel Functionality in Pressurized SP-SHR Arteries
The impact of dysfunctional β1 subunit trafficking was investigated by measuring the contractility of pressurized cerebral arteries. At an intravascular pressure of 60 mm Hg, endothelium-denuded SP-SHR arteries developed 36.1±1.8% tone compared with 23.9±4.0% tone in WKY arteries or ≈1.5-fold more (n=6; P<0.05). SNP and lithocholate increased the mean diameter of SP-SHR arteries by ≈4 and 6 μm, respectively, responses that were ≈26% and 48% of those in WKY rat arteries ( Figure 6A and 6B). SNP (10 minutes) increased lithocholate-induced dilation from ≈6 to 20 µm in WKY rat arteries and from ≈3 to 7 µm in SP-SHR arteries. Thus, lithocholate-induced vasodilation in the presence of SNP was ≈2.8-fold more in WKY than SP-SHR arteries ( Figure 6B ). BIM increased SNP-induced vasodilation in SP-SHR arteries to the same as in WKY rat arteries ( Figure 6B ). BIM also increased lithocholate-induced vasodilation obtained in the presence of SNP in SP-SHR arteries to the same as that in WKY rat arteries ( Figure 6B ). In contrast, BIM alone did not alter WKY rat or SP-SHR artery diameter ( Figure 6B ). BIM also did not alter vasodilation to SNP or lithocholate in WKY rat arteries ( Figure 6B ). These data support our biochemical evidence that activated PKC inhibits mobilization of myocyte β1 subunits and greatly attenuates BK channel function in SP-SHR arteries.
Discussion
Here, we tested the hypothesis that hypertension is associated with altered trafficking of BK channel subunits in myocytes of cerebral arteries using SP-SHRs as a disease model and WKY rats as a control. Our data show that stimulated surface trafficking of β1 subunits by NO or membrane depolarization is inhibited in arterial myocytes of SP-SHRs. PKCα and βII total protein and activity were both higher in SP-SHR arteries. PKC inhibition or expression of Rab11A S177A, a PKC phosphorylation-deficient mutant, restored β1 subunit surface-trafficking in SP-SHR arteries. The impaired trafficking of β1 subunits prevents BK channel activation by NO in arterial myocytes of SP-SHRs. BK channel activation by NO is restored by Rab11A S177A in SP-SHR myocytes. PKC inhibition also enables NO-induced vasodilation by reestablishing the ability of NO to increase the abundance of β1 subunits associated with surface BKα. These data demonstrate that spontaneously active PKC blocks the ability of NO to stimulate β1 subunit surface trafficking in myocytes of SP-SHR, thereby preventing BK channel activation and vasodilation in cerebral arteries of SP-SHR.
Cerebral arteries from hypertensive subjects are depolarized and constricted. 2, 3 Endothelium-dependent vasodilation, including that produced by NO, is attenuated in vessels from multiple hypertensive animal models. [22] [23] [24] [25] [26] [27] [28] [29] Given that BK channels regulate physiological arterial potential and contractility, we investigated whether pathological changes in BK channel trafficking alter arterial function during hypertension. We used SP-SHR, a rat genetic model of hypertension that is prone to stroke, to study the cellular distribution and regulation of BKα and β1 subunit total and surface abundance. Our data show that BKα and β1 total and surface proteins are similar in cerebral arteries of age-matched hypertensive SP-SHRs and normotensive WKY rat controls. Our data are in agreement with the findings of some, but not all, previous studies that measured either subunit message or total protein in cerebral arteries. Consistent with our results, Pabbidi reported that BKα and β1 total proteins were similar in cerebral arteries of a hypertensive model of Fawn-Hooded rats, when compared with their normotensive genetic controls. 30 Other studies have reported that BKα mRNA is unaltered, but β1 mRNA was lower in cerebral arteries of Ang II-infused hypertensive Sprague-Dawley rats and mice and SHRs, when compared with their respective controls. 8, 9 Another study found that although BKα mRNA was similar, BKα protein was higher in cerebral arteries of SHR and WKYs. 31 Some of these different findings may relate to the approaches used to measure BK channel subunit expression or the animal models of hypertension that were examined. Regardless, our data show that the altered functionality of BK channels described here in SP-SHR cerebral arteries is not because of a change in the amount of BKα or β1 total proteins.
We previously described that in unstimulated arteries, low levels of β1 subunits are trafficked to the surface via a Rab11A-independent mechanism. 12 Our data here suggest that the surface-trafficking of these basal β1 subunits is not altered in SP-SHR. NO and membrane depolarization stimulate Rab11A-dependent trafficking of β1 subunits to the plasma membrane in arterial myocytes but through distinct signaling mechanisms: NO operates through PKG activation, whereas depolarization acts via the stimulation of ROCK. 12, 15 Regardless of the signaling mechanisms involved, surfacetrafficked β1 proteins associate with plasma membrane-resident BKα, leading to channel activation. 12, 15 Here, NO and membrane depolarization failed to surface-traffic β1 subunits in cerebral arteries of SP-SHRs. Data show that although total Rab11A is lower in SP-SHR arteries, Rab11A overexpression did not reestablish β1 trafficking, consistent with the mechanism being inhibitory, rather than through the loss of Rab11A protein. The mechanism leading to a reduction in total Rab11A protein in SP-SHR arteries was not determined here but would be relevant to determine in future studies. We recently described that ET-1 activates PKC, which phosphorylates Rab11A at Serine 177. 16 This mechanism inhibits Rab11A, which blocks β1 subunit surface trafficking in arterial myocytes. 16 Given that NO stimulates Rab11A in normotensive rat arterial myocytes, it lead us to hypothesize that activated PKC may prevent β1 trafficking in arterial myocytes of SP-SHRs. 16 Here, active PKCα/βII and active Rab11 were measured using antibodies. Phosphorylation of PKCα and PKCβII on Thr638/641 increases catalytic activity. 32, 33 The phosphorylation state of PKCα/βII recognized by the antibody here is directly related to activity. Rab11 activity was measured using an antibody that recognizes the GTP-bound active form of Rab11, but does not recognize the GDP-bound inactive form. Data support our hypothesis proposed, including that PKCα and βII protein and activity are higher in SP-SHR than WKY arteries. SNP and membrane depolarization robustly activated Rab11 in arterial myocytes of WKY rats, but only slightly increased Rab11 activity in myocytes of SP-SHRs. BIM and Rab11A S177A, a Rab11A mutant that is unable to be phosphorylated by PKC at serine 177, enabled NO-induced trafficking of β1 subunits in SP-SHR arteries. Thus, spontaneously active PKC phosphorylates Rab11A at serine 177, which inhibits stimulated surface trafficking of β1 subunits by NO and membrane depolarization in SP-SHR myocytes. Rab11A S177 expression did not increase surface β1 subunits in unstimulated myocytes, suggesting that it is not PKC phosphorylation of Rab11A, which maintains the basal intracellular localization of β1. Rather, our results suggest that in unstimulated myocytes, β1 subunits reside in recycling endosomes and an anterograde trafficking stimulus, such as NO or membrane depolarization is necessary to mobilize these protein to the surface. Identifying the mechanism by which PKC is spontaneously activated in arteries of SP-SHRs was not a focus of our study, but several possibilities exist. An increase in the expression, translocation, and activity of PKC has been implicated in the pathogenesis of hypertension and 1 or more of these signaling alterations may underlie PKCmediated Rab11A inhibition in SP-SHR arterial myocyte. 34 Our data show that PKC is active in unstimulated arteries in vitro. The PKC-mediated inhibitory mechanism was also present in arteries that had been placed in serum-free media for 2 days. These data suggest that the mechanism of PKC activation occurs in the isolated arterial wall and that in vivo factors, such as circulating vasoconstrictors, are not required for this PKC activity and inhibition of β1 trafficking in arterial myocytes of SP-SHRs. PKC can be activated by many different intracellular signal elements, including diacylglycerol, Ca
2+
, and reactive oxygen species. Studies have shown that intracellular Ca 2+ concentration and Ca 2+ sparklet activity are increased in arterial myocytes during hypertension. 1, 10 Hypertension is also associated with an increase in the bioavailability of vascular reactive oxygen species. 35 One or more of these multiple mechanisms may activate PKC, leading to the inhibition of β1 trafficking in arterial myocytes of SP-SHRs.
BK channels formed from 4 α subunits can contain between 1 and 4 β1 subunits. 36, 37 The α β1-tetramer ratio shifts channel voltage and Ca 2+ dependence, with an increase in the number of β1 subunits elevating channel activity. 36 We applied lithocholate directly to inside-out patches to evaluate the presence of channels containing β1 subunits. Although surface β1 protein was similar in unstimulated WKY and SP-SHR myocytes, lithocholate activated BK channels only in patches from WKY rats and not in patches from SP-SHRs. Thus, plasma membrane β1 subunits do not activate BK channels in unstimulated SP-SHR arterial myocytes. Explanations for this finding include that a pathological signaling mechanism prevents low levels of β1 subunits from either activating or physically associating with BKα in SP-SHR myocytes. SNP increased both BK channel P O and lithocholate-induced channel activation in excised patches from WKY rat myocytes, indicating that NO increased the abundance of β1 subunits associated with BKα. In contrast, SNP did not activate BK channels or enable lithocholate-induced BK channel activation in SP-SHR myocytes, consistent with other data here that NO did not traffic β1 subunits to the surface in these cells. The overexpression of Rab11A did not enable NO-or lithocholate-activation of BK channels in SP-SHR arterial myocytes. In contrast, Rab11A S177A reestablished both NO-and lithocholate-activation of BK channels. These data suggest that PKC acting through Rab11A S177 inhibits β1 subunit surface-trafficking, thereby preventing NO from activating BK channels.
Arterial myocyte BK channels are activated by localized intracellular Ca 2+ transients, termed Ca 2+ sparks, that occur because of the release of sarcoplasmic reticulum Ca 2+ through RyRs (ryanodine receptors). 6 A single Ca 2+ spark activates multiple nearby BK channels, leading to a transient BK current. 6 Ca 2+ spark frequency essentially determines transient BK current frequency, whereas the effective coupling of BK channels to Ca 2+ sparks is the primary factor, which establishes the amount of current produced by each BK transient. 7 We have previously shown that ET-1 activates PKC, which inhibits β1 subunit surface trafficking, leading to BK channel inhibition and a decrease in transient BK currents in arterial myocytes. 16 Ca 2+ spark frequency was similar, whereas the coupling between Ca 2+ sparks and BK channels were attenuated in cerebral artery myocytes of hypertensive rats. 8 Here, activated PKC blocks β1 subunit surface-trafficking, which would reduce the effective coupling of BK channels to Ca 2+ sparks and reduce transient BK currents.
Functional data also support the signaling mechanism identified here using biochemistry and electrophysiology. In pressurized WKY rat arteries, SNP and lithocholate both stimulated dilation, SNP increased lithocholate-induced vasodilation and BIM did not alter these responses. In contrast, in SP-SHR arteries, SNP and lithocholate-induced dilations were small, SNP did not increase lithocholate-induced dilation, BIM increased SNP-induced vasodilation and enabled SNP to augment dilation to lithocholate. Importantly, BIM increased SNP-induced vasodilation such that it was the same as in WKY rat arteries. These data indicate that PKC-mediated inhibition of β1 subunit trafficking underlies dysfunctional NO-induced vasodilation in SP-SHR cerebral arteries. As discussed above, studies have reported either no change or alterations in the abundance of BK channel subunits in hypertensive animal models. The upregulation of BK currents in arterial myocytes during SHRs is reported to elicit compensatory vasodilation. 31 In contrast, a reduction in β1 subunits has been described to decrease BK channel activity, producing vasoconstriction in Ang II-infused hypertensive Sprague-Dawley rats and mice and SHRs. [8] [9] [10] Our data indicate that BKα and β1 total protein are unaltered and myogenic tone is higher in pressurized arteries of SP-SHRs than WKY rats. It was not a focus of this study to investigate the underlying mechanisms for increased myogenic tone and whether BK channels contribute to this vasoconstriction or oppose it. BIM alone did not alter the diameter of either WKY rat or SP-SHR arteries, suggesting that the net effect of PKC activation does not contribute to the increase in myogenic tone. Other mechanisms, including those mediated through voltage-dependent K + (K V ) and Ca V 1.2 channels contribute to this pathological vasoconstriction. 1 Our data show that NO-induced vasodilation is attenuated because of PKC-mediated inhibition of β1 subunit trafficking in cerebral arteries of SP-SHRs.
Findings of our study may be relevant for human cardiovascular diseases. Single nucleotide polymorphisms in KCNMA1 and KCNMB1 genes contribute to human cardiovascular diseases, including hypertension. 38 More than 140 single nucleotide polymorphisms have been reported in or nearby the KCNMB1 gene. An E65K polymorphism in β1 produces a gain-of-function mutant, which increases BK channel Ca 2+ -sensitivity and is associated with lower prevalence for diastolic hypertension. 39 BK channel apparent Ca
-sensitivity is lower in β1 subunit knockout mice, which leads to membrane depolarization, vasoconstriction, and systemic hypertension. 11 These studies provide a link between altered β1 subunit function, vascular reactivity, and blood pressure. Whether SNPs in β1 subunits interfere with protein surface trafficking is unclear, but would be relevant to investigate given findings reported here.
Perspectives
In summary, we show that that activated PKC blocks the surface trafficking of β1 subunits by Rab11A, which prevents BK channel activation in arterial myocytes of SP-SHRs. Blocking this PKC-mediated inhibitory mechanism restores the stimulated surface trafficking of β1 subunits, enabling BK channel activation and vasodilation. The identification of both this dysfunctional signaling pathway and a mechanism to block it may lead to the development of novel therapies that reduce vascular disease in hypertensive subjects.
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